Newsfeeds - Spark Newswire

1 minute read

Events
News

Connect Biopharma Presents Data And Analyses From The Global Phase 2b Trial Of CBP-201 At The Maui Derm Conference

Today, 9:03 AM

—Data provides detailed results, with achievement of both primary and key secondary end points and demonstrating significant improvements in skin clearance, disease severity, and itch compared to

CNTB

5 minute read

Connect Biopharma’s Latest Dermatitis Drug Update Fails to Pump Up Shares

By The Bamboo Works

Today, 9:03 AM

Key takeaways: Loss-making Connect Biopharma says Phase 3 clinical trials of its CBP-201 drug for atopic dermatitis will begin in second half of this year Connect Biopharma shares, which more than halved after its November release of initial Phase 2 clinical trial data, fell further after latest update By Mia Shanley

CNTB

5 minute read

58 Biggest Movers From Yesterday

By Lisa Levin

Today, 9:03 AM

Gainers Eargo, Inc. (NASDAQ: EAR) shares climbed 59.7% to close at $7.28 on Thurs after the company announced the Department of Justice confirmed to it that the previously-announced criminal probe is no long active.

AACG

1 minute read

10 Biggest Price Target Changes For Thursday

By Lisa Levin

Today, 9:03 AM

JP Morgan raised the price target for RPM International Inc. (NYSE: RPM) from $85 to $100. RPM shares rose 0.5% to $97.90 in pre-market trading.

AKAM

4 minute read

50 Biggest Movers From Yesterday

By Lisa Levin

Today, 9:03 AM

Gainers

AACG

1 minute read

SVB Leerink Maintains Outperform on Connect Biopharma Hldgs, Lowers Price Target to $22

By Benzinga Newsdesk

Today, 9:03 AM

SVB Leerink analyst Thomas Smith maintains Connect Biopharma Hldgs (NASDAQ:CNTB) with a Outperform and lowers the price target from $32 to $22.

CNTB

3 minute read

34 Stocks Moving In Wednesday’s Mid-Day Session

By Lisa Levin

Today, 9:03 AM

Gainers Mainz Biomed B.V. (NASDAQ: MYNZ) shares climbed 49.7% to $15.45 after the company announced it acquired exclusive rights to novel mRNA biomarkers.

AACG

3 minute read

The Week Ahead In Biotech (Nov. 21-Nov. 27): Takeda, Aadi, Fennec FDA Decisions, Earnings In The Spotlight In Holiday-Shortened Week

By Shanthi Rexaline

Today, 9:03 AM

Biotech stocks showed a lack of direction in the week ending Nov. 19 before finishing modestly higher. Stocks did not have much meaningful catalysts to react to amid the winding down of the reporting season and ahead of the holiday week.

AADI

3 minute read

Mid-Afternoon Market Update: Dow Falls 200 Points; Connect Biopharma Shares Tumble

By Lisa Levin

Today, 9:03 AM

Toward the end of trading Friday, the Dow traded down 0.58% to 35,664.58 while the NASDAQ rose 0.53% to 16,078.19. The S&P also rose, gaining 0.05% to 4,706.69.

AVDX

3 minute read

Mid-Day Market Update: Crude Oil Down Over 4%; UWM Holdings Shares Surge

By Lisa Levin

Today, 9:03 AM

Midway through trading Friday, the Dow traded down 0.62% to 35,648.81 while the NASDAQ rose 0.53% to 16,078.23. The S&P also fell, dropping 0.01% to 4,704.35.

AVDX